His scientific interests lie mostly in Cancer research, Lymphoma, Anaplastic lymphoma kinase, Immunology and Molecular biology. His Cancer research research is multidisciplinary, relying on both Carcinogenesis, T cell, Anaplastic large-cell lymphoma, Cell cycle and STAT3. Lymphoma is a primary field of his research addressed under Pathology.
He has researched Anaplastic lymphoma kinase in several fields, including Nucleophosmin, Tyrosine kinase, Receptor Protein-Tyrosine Kinases, Signal transduction and Transfection. The study incorporates disciplines such as Mutation and Epigenetics in addition to Immunology. His Molecular biology research integrates issues from Genetics, Gene and Exon.
His primary scientific interests are in Cancer research, Lymphoma, Immunology, Anaplastic lymphoma kinase and Internal medicine. His biological study spans a wide range of topics, including T cell, Diffuse large B-cell lymphoma, Signal transduction, Anaplastic large-cell lymphoma and Leukemia. His work carried out in the field of Lymphoma brings together such families of science as Cancer, Genetics and Gene expression profiling.
His Immunology research is multidisciplinary, incorporating elements of Cancer cell, Cytotoxic T cell and Cell culture. His research in Anaplastic lymphoma kinase intersects with topics in Tyrosine kinase, Crizotinib and PRDM1. His work in Internal medicine addresses subjects such as Oncology, which are connected to disciplines such as Adenocarcinoma.
His main research concerns Cancer research, Lymphoma, Internal medicine, Oncology and Diffuse large B-cell lymphoma. His biological study spans a wide range of topics, including Cell culture, B cell, Peripheral T-cell lymphoma, Signal transduction and Anaplastic large-cell lymphoma. His research in Anaplastic large-cell lymphoma tackles topics such as Anaplastic lymphoma kinase which are related to areas like Small hairpin RNA and RNA interference.
Giorgio Inghirami works mostly in the field of Lymphoma, limiting it down to topics relating to Angioimmunoblastic T-cell lymphoma and, in certain cases, Cancer. Giorgio Inghirami interconnects CHOP, Febrile neutropenia, Adult Acute Lymphoblastic Leukemia and Minimal residual disease in the investigation of issues within Oncology. In his research on the topic of Diffuse large B-cell lymphoma, Cell lineage and Vincristine is strongly related with Gene expression.
Giorgio Inghirami mainly focuses on Cancer research, Lymphoma, Internal medicine, Signal transduction and Peripheral T-cell lymphoma. His Cancer research study combines topics from a wide range of disciplines, such as Pathogenesis, Transcription factor, Transcriptional regulation, B cell and Promoter. His study of Anaplastic large-cell lymphoma is a part of Lymphoma.
He studied Anaplastic large-cell lymphoma and T-cell lymphoma that intersect with Anaplastic lymphoma kinase and Tyrosine kinase. Giorgio Inghirami works mostly in the field of Anaplastic lymphoma kinase, limiting it down to topics relating to IRF4 and, in certain cases, Gene expression profiling, as a part of the same area of interest. His work is dedicated to discovering how Internal medicine, Oncology are connected with Minimal residual disease, Hematology and Early Relapse and other disciplines.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Gene Expression Profiling of B Cell Chronic Lymphocytic Leukemia Reveals a Homogeneous Phenotype Related to Memory B Cells
Ulf Klein;Yuhai Tu;Gustavo A. Stolovitzky;Michela Mattioli.
Journal of Experimental Medicine (2001)
p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia.
Gianluca Gaidano;Paola Ballerini;Jerry Z. Gong;Giorgio Inghirami.
Proceedings of the National Academy of Sciences of the United States of America (1991)
BRAF mutations in hairy-cell leukemia
Enrico Tiacci;Vladimir Trifonov;Gianluca Schiavoni;Antony Holmes.
The New England Journal of Medicine (2011)
The anaplastic lymphoma kinase in the pathogenesis of cancer.
Roberto Chiarle;Claudia Voena;Chiara Ambrogio;Roberto Piva;Roberto Piva.
Nature Reviews Cancer (2008)
Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors.
Donald Kufe;Giorgio Inghirami;Miyako Abe;Daniel Hayes.
DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity.
Claire Vanpouille-Box;Amandine Alard;Amandine Alard;Molykutty J. Aryankalayil;Yasmeen Sarfraz.
Nature Communications (2017)
Human lymphocytes making rheumatoid factor and antibody to ssDNA belong to Leu-1+ B-cell subset
Paolo Casali;Samuele E. Burastero;Minoru Nakamura;Giorgio Inghirami.
In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences
Ethel Cesarman;Patrick S. Moore;Pulirarthy H. Rao;Giorgio Inghirami.
β4 Integrin Amplifies ErbB2 Signaling to Promote Mammary Tumorigenesis
Wenjun Guo;Yuliya Pylayeva;Yuliya Pylayeva;Angela Pepe;Toshiaki Yoshioka.
Correction: Corrigendum: THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors
Florencia Cayrol;Pannee Praditsuktavorn;Tharu M. Fernando;Nicholas Kwiatkowski.
Nature Communications (2017)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: